Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism - PubMed
Review
. 2001 Jun;73(4):438-452.
doi: 10.1007/BF02994005.
Affiliations
- PMID: 11503957
- DOI: 10.1007/BF02994005
Review
Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism
Akira Yuo. Int J Hematol. 2001 Jun.
Abstract
Human myeloid cells include hematopoietic cells at various stages of differentiation, from immature myeloid cells to mature phagocytes. Normal immature myeloid cells undergo differentiation concomitantly with proliferation in response to hematopoietic growth factors, and terminally differentiated cells, ie, mature phagocytes, exert their effector functions and then die a natural death via apoptosis. However, leukemic myeloid cells are induced to differentiate with growth suppression by several inducers, such as retinoic acid. This review describes differentiation, apoptosis, and functionality of human myeloid cells. mainly focusing on the intracellular signaling mechanism. The signal transduction system for these biological events of the life cycle of myeloid cells has recently been studied, and several characteristics have been elucidated. First, the signaling pathway for myeloid differentiation is mainly focused in the mitogen-activated protein kinases, such as extracellular signal-regulated kinase and p38, and transcriptional factors such as the signal transducers and activators of transcription PU.1 and CCAAT enhancer binding protein. Second, the signaling mechanism for myeloid cell apoptosis is fundamentally identical to that found in other cells. Caspases, caspase-activated DNase, and mitochondrial molecules such as apoptosis-inducing factor have been reported to be important, and mitogen-activated protein kinases such as p38 appear to be less important. Finally, p38 and phosphatidylinositol 3-kinase play critical roles in the signaling cascade for functional activation of mature phagocytes. The reasons why the same signaling molecules play distinct roles according to the differentiation stage and biological event await future clarification.
Similar articles
-
Signal transduction pathways that contribute to myeloid differentiation.
Miranda MB, Johnson DE. Miranda MB, et al. Leukemia. 2007 Jul;21(7):1363-77. doi: 10.1038/sj.leu.2404690. Epub 2007 Apr 19. Leukemia. 2007. PMID: 17443228 Review.
-
Takada Y, Sethi G, Sung B, Aggarwal BB. Takada Y, et al. Mol Pharmacol. 2008 May;73(5):1549-57. doi: 10.1124/mol.107.041350. Epub 2008 Feb 20. Mol Pharmacol. 2008. PMID: 18287248 Retracted.
-
Gadd45 in the response of hematopoietic cells to genotoxic stress.
Liebermann DA, Hoffman B. Liebermann DA, et al. Blood Cells Mol Dis. 2007 Nov-Dec;39(3):329-35. doi: 10.1016/j.bcmd.2007.06.006. Epub 2007 Jul 30. Blood Cells Mol Dis. 2007. PMID: 17659913 Free PMC article. Review.
Cited by
-
Investigating the immune mechanism of natural products in the treatment of lung cancer.
Yang L, Chen Y, Liu K, Chen Y, Zhang Y, Zhang Z, Li H. Yang L, et al. Front Pharmacol. 2024 Feb 14;15:1289957. doi: 10.3389/fphar.2024.1289957. eCollection 2024. Front Pharmacol. 2024. PMID: 38420194 Free PMC article. Review.
-
Doshi M, Koyanagi M, Nakahara M, Saeki K, Saeki K, Yuo A. Doshi M, et al. Int J Hematol. 2006 Oct;84(3):231-7. doi: 10.1532/IJH97.06040. Int J Hematol. 2006. PMID: 17050197
-
Figarola JL, Weng Y, Lincoln C, Horne D, Rahbar S. Figarola JL, et al. Invest New Drugs. 2012 Aug;30(4):1413-25. doi: 10.1007/s10637-011-9711-8. Epub 2011 Jul 5. Invest New Drugs. 2012. PMID: 21728022
-
Bhattacharya U, Halder B, Mukhopadhyay S, Giri AK. Bhattacharya U, et al. Cancer Sci. 2009 Oct;100(10):1971-8. doi: 10.1111/j.1349-7006.2009.01251.x. Epub 2009 Jun 22. Cancer Sci. 2009. PMID: 19594545 Free PMC article.